Welcome to Emergency Medicine Cases.com.

I'm your host, Dr. Anton Hellman, bringing you Canada's brightest minds in emergency medicine from EMC Studios in Toronto.

In this episode number 37, the second part of transfusions, anticoagulants, and bleeding, we have again Dr. Walter

Himmel, Dr. Katarina Povinsky, and Dr. Jeanne Callum.

Dr. Himmel is an emergency physician at North York General, Scarborough General, and Toronto

East General Hospitals.

He's a world-renowned speaker in emergency medicine on topics of stroke, anticoagulants,

transfusions, and drug interactions,

and the recipient of multiple teaching awards. Dr. Katerina Pavensky is the head of

transfusion medicine and a medical director of the Blood Conservation and Therapeutic Aferesis Services

at St. Michael's Hospital in Toronto. She's an assistant professor in the Department of

Pathobiology and Laboratory Medicine.

She's the chair of the St. Michael's Hospital Transfusion Committee and is on the board of directors of the Canadian Society of Transfusion Medicine.

Dr. Jeannie Callum is the Director of Transfusion Medicine and Tissue Banks at Sunnybrook's Health Sciences Center in Toronto,

an associate professor of the Department of Laboratory

Medicine and Pathobiology at the University of Toronto. She serves as a sponsor lead for the

Ontario Regional Blood Coordinating Network for Central Ontario as an active researcher in transfusion

medicine. We're going to lead off with the pros and cons of the newer anticoagulants.

So let's get into talking about these newer anticoagulant alternatives to warfarin.

These are Debigotran, the trade name is Pratax, Rabiraban, trade name is Zarelto, and Apixaban, and the trade name is Elyquist.

Did I say that right? Eliquidly.

So some docs are changing all their patients over from Warfarin to one of these new anticoagulants,

...